-+ 0.00%
-+ 0.00%
-+ 0.00%

Biosergen Gets Approval for Nasdaq First North Growth Market Delisting

MT Newswires·09/17/2026 11:30:14
Listen to the news
11:30 AM EDT, 09/17/2026 (MT Newswires) -- Biosergen (BIOSGN.ST) secured approval to delist from Nasdaq First North Growth Market, with its final trading day set for Oct. 21, according to a Thursday release. The application follows the biotechnology company's planned merger with life science investor Flerie (FLERIE.ST), which is conditional on the Swedish Companies Registration Office's approval, expected around Oct. 15. Registration is set to follow on Oct. 23.